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Recently, the interest in extracellular vesicles (EVs) released by pathogens like bacteria,
fungi, and parasites has rapidly increased. Many of these pathogens actively modulate
the immune responses of their host and there is accumulating evidence that pathogen-
derived EV contribute to this process. The effects of pathogen-derived EV on the host
immune system have been attributed to proteins, lipids, nucleic acids, and glycans
contained in, or present on these EV. For example, toxins in bacterial EV can modulate
pathogen clearance and antigen presentation, while EV-associated polysaccharides
are potential vaccine targets because they induce protective immune responses.
Furthermore, parasite EV-associated microRNA may increase parasite survival via host
gene repression, and the lipid A moiety of LPS in bacteria-derived EV induces strong
pro-inflammatory responses. Research on pathogen EV-associated molecules may
pave new avenues to combat infectious diseases by immune intervention. This review
provides an overview of the current knowledge of EV-associated molecules released by
extracellular pathogens and their effects on the host immune system. The current focus
and future hotspots of this rapidly expanding field will be highlighted and discussed.
Keywords: extracellular vesicles, pathogen, host, immune response, lipid, protein, nucleic acid, glycan
INTRODUCTION
An increasing number of studies documenting the molecular characteristics and the function
of pathogen-derived extracellular vesicles (EVs) suggest that pathogen EV play important roles
in the activation and modulation of the host immune system. However, only few reports
assign EV-mediated effects to specific EV-associated molecules or molecular principles. Here, we
focus on defined pathogen-derived EV-associated molecules, their immunomodulatory effects,
and the implications for host–pathogen interactions. We first briefly discuss pathogen–host
communication via EV and EV biogenesis. Next, various classes of molecules in pathogen-derived
EV—proteins, lipids, glycans (carbohydrate chains), and nucleic acids—will be addressed with
respect to molecular identity and function. With this approach we aim to outline the current
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understanding of molecular principles through which pathogen
EV modulate immune responses of their hosts.
PATHOGEN–HOST COMMUNICATION:
SENDING MESSAGES VIA
EXTRACELLULAR VESICLES
Many pathogens, including bacteria, fungi and parasites, have
evolved to survive and reproduce in their host environment.
For their success, modulation of the host immune system is
often crucial. Simultaneously, the mammalian innate immune
system has evolved to recognize and respond to the invading
pathogens in order to eliminate them. Various pathogen-
associated molecular patterns (PAMPs)—such as proteins, lipids,
glycans, and nucleic acids—can bind to different families
of pattern recognition receptors (PRRs), including Toll-like
receptors (TLRs), C-type lectin receptors (CLRs), and NOD-
like receptors (NLRs), expressed by both immune and non-
immune cells in the host. While the activation of PRRs by
PAMPs is essential for immunity and host defense, pathogens
have developed several modulatory mechanisms to interfere
in PRR binding and signaling (Takeuchi and Akira, 2010;
Kumar et al., 2011; Blander and Sander, 2012). In addition
to PAMPs, pathogens can employ other molecules to increase
their survival. For instance, cytotoxic proteins that induce
apoptosis, enzymes targeting intracellular signaling pathways, or
host gene regulating micro(mi)RNAs (Santos and Finlay, 2015;
Poole et al., 2018). Classically, PAMPs and other pathogen-
derived immunomodulatory molecules are found on the surface
of pathogens or they are released as secretory biomolecules.
Recently, however, it has become clear that PAMPs and other
immunomodulatory molecules can also be released into the
extracellular space as part of EV.
Extracellular vesicles are a collective term for exosomes,
microvesicles, and other cell-derived membrane-enclosed
vesicles. These vesicles transport various molecules, including
proteins, lipids, and nucleic acids between cells within one
organism or between organisms, such as in host–pathogen
cross-talk. Mammalian EV contain a mix of endosomal
and plasma membrane proteins, including tetraspanins and
major histocompatibility complex (MHC) molecules, and
cytosolic proteins such as cytoskeletal proteins and heat shock
proteins (Yanez-Mo et al., 2015). Lipids are essential for the
formation and structure of the EV bilayer and EV are mainly
enriched in cholesterol, sphingomyelin, phosphatidylserine, and
glycosphingolipids. In addition, mammalian EV can transfer
bioactive lipids and lipid-related enzymes between cells, such as
prostaglandin E2 and phospholipase A2, respectively (Record
et al., 2014). The most abundant nucleic acids in EV are small
RNA species (<200 nucleotides) (Nolte-‘t Hoen et al., 2012), but
mRNA, long non-coding RNA, and DNA have also been detected
(Yanez-Mo et al., 2015). A lot of research has been dedicated
to the characterization of EV-derived miRNA because of their
well-known capacity to modulate gene expression. Additionally,
EV contain glycans (Gerlach and Griffin, 2016) that are present
as part of larger glycoconjugates, such as glycolipids and
proteoglycans, or as post-translational modification of proteins.
Given that the variation and heterogeneity in glycoconjugates
is very high, EV-associated glycans may serve multiple and
dedicated roles in both the biogenesis and function of EV
(Costa, 2017). The molecular composition of mammalian- and
pathogen-derived EV is highly dynamic and depends on the type
of EV-producing cell/organism, the developmental/physiological
status of that cell/organism, and environmental conditions
(Yanez-Mo et al., 2015). Therefore, the functional behavior
of these EV and their effects on recipient cells are probably
‘donor’ cell/organism- and niche/context-specific (Nolte-‘t
Hoen and Wauben, 2012). The immunological imprinting by
EV has been spearheaded by previous studies on EV derived
from mammalian immune cells (reviewed in Thery et al., 2009;
Nolte-‘t Hoen and Wauben, 2012; Robbins and Morelli, 2014),
tumor cells (reviewed in Tkach and Thery, 2016; Wendler et al.,
2016) and mesenchymal stromal/stem cells (reviewed in Bruno
et al., 2015; Lener et al., 2015; Stephen et al., 2016).
The release of pathogen-derived vesicles was observed
40–50 years ago in gram-negative bacteria, Vibrio cholerae
(Chatterjee and Das, 1967) and Neisseria meningitidis (Devoe
and Gilchrist, 1973), the fungus Cryptococcus neoformans (Takeo
et al., 1973), and the parasites Schistosoma mansoni and
Fasciola hepatica (Senft et al., 1961; Threadgold, 1963). These
vesicles were initially regarded as artifacts, until decades later,
studies on gram-negative bacteria showed that their released
outer membrane vesicles supported bacterial survival. Indeed,
bacterial vesicles contributed to biofilm formation (Schooling
and Beveridge, 2006) and were able to transfer DNA to
other bacteria, thereby sharing genes involved in, for example,
antibiotic resistance (Renelli et al., 2004; Mashburn-Warren
and Whiteley, 2006). In the past decade, evidence was also
provided for release of EV by gram-positive bacteria (Dorward
and Garon, 1990), fungi (Rodrigues et al., 2007), parasites
(Silverman et al., 2010), parasite-infected cells, like Plasmodium
falciparum-infected red blood cells (Mantel et al., 2013), and
the pathogenic protozoa Acanthamoeba castellanii (Goncalves
et al., 2018). The description of EV released by pathogen-
infected cells is beyond the scope of this review and has been
extensively described elsewhere (Schwab et al., 2015; Nolte-
‘t Hoen et al., 2016; Rodriguez and Prados-Rosales, 2016;
Szempruch et al., 2016). In this review, we focus on EV
released by extracellular pathogens and their direct effects on the
host.
EXTRACELLULAR VESICLE BIOGENESIS
IN MAMMALS AND PATHOGENS
Despite growing numbers of studies on EV biogenesis in
mammalian cells, full details of the molecular pathways involved
are not yet resolved (van Niel et al., 2018). So far, it is known
that various sorting machineries are involved in clustering
membrane-associated proteins and lipids destined for secretion
via EV. This clustering occurs within membrane microdomains
found on the limited membrane of the multivesicular endosome
(MVE, also called multivesicular body) and on the plasma
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FIGURE 1 | Brief schematic summary of known mammalian extracellular vesicle (EV) biogenesis and their fate in recipient cells. Proteins, lipids, and sorting
machineries cluster in microdomains of the plasma membrane or limited membrane of the multivesicular endosome (MVE) and can recruit molecules from the
cytosol (top). Furthermore, components of the sorting machinery contribute to microvesicle or intraluminal vesicle (ILV) formation. Microvesicles bud off the plasma
membrane, while ILVs are released as exosomes once the MVE fuses with the plasma membrane. Released EV can interact with a recipient cell via receptor binding,
fusion, or various internalization routes (bottom). After endocytosis, EV will be either degraded in lysosomes or end up in MVEs with endogenous ILVs. Intraluminal
cargo can only be released into the cytosol of the recipient cell upon fusion of EV with the plasma membrane or MVE membrane. ESCRT, endosomal sorting
complex required for transport.
membrane (Figure 1). Although the biogenesis of vesicles within
the MVE is better understood than vesicle biogenesis at the
plasma membrane, both routes share molecular machineries for
EV generation, such as ‘Endosomal Sorting Complex Required
for Transport’ (ESCRT) proteins and tetraspanins. Both ESCRT-
dependent and independent mechanisms have been implicated
in clustering of cargo for biogenesis of EV (Colombo et al.,
2014). The microdomain-associated molecules have also been
suggested to participate in recruiting soluble proteins and
ribonucleoprotein complexes from the cytosol into the vesicles.
Budding of EV from the plasma membrane or into the lumen of
MVE is often ESCRT dependent. The type of recruited sorting
machinery likely determines whether the MVE will fuse with
the plasma membrane or with lysosomes (Ostrowski et al.,
2010). Upon fusion of the MVE with the plasma membrane,
the intraluminal vesicles (ILVs) are released into the extracellular
space and then referred to as exosomes. EV budding from the
plasma membrane are often called microvesicles. A schematic
overview of EV biogenesis pathways is shown in Figure 1 (top).
For further details on the biogenesis of mammalian EV, we refer
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to a recently published comprehensive review on this topic (van
Niel et al., 2018).
With regard to pathogen-derived EV, the release of EV by
parasites shows most similarities with EV release by mammalian
cells. Transmission electron microscopic (TEM) analysis of
multicellular parasites, such as F. hepatica (de la Torre-Escudero
et al., 2016), and unicellular protozoan parasites, such as
Trypanosoma cruzi (Bayer-Santos et al., 2013), indicated budding
of microvesicles from the plasma membrane and the presence
of ILVs in MVEs. Interestingly, a third secretion route was
described for T. cruzi and Leishmania spp. where vesicles are
released from an organelle involved in protein endocytosis and
exocytosis called the flagellar pocket (Silverman et al., 2008;
Bayer-Santos et al., 2013; Atayde et al., 2015). However, whether
these flagellar membrane-derived EV differ in molecular content
compared to the EV released via the other two routes remains
unknown (Szempruch et al., 2016). In addition, proteomic studies
on EV from many different parasite species (excluding the strictly
intracellular parasites) have indicated the presence of molecular
orthologs of proteins involved in EV biogenesis, including
ESCRT components, the tetraspanin CD63, and vacuolar protein
sorting-associated protein 4 (VPS4) (Mantel and Marti, 2014;
de la Torre-Escudero et al., 2016). These findings suggest that
EV formation is highly conserved in eukaryotes. It is less clear
how fungi-derived vesicles are formed. TEM of C. neoformans
showed MVE-like structures and ESCRT proteins have been
detected in EV from Saccharomyces cerevisiae. ESCRT proteins
were not required for EV release in S. cerevisiae, but played a
role in determining the protein composition of EV (Rodrigues
et al., 2015). Furthermore, it is not known how fungal EV
traverse the complex fungal cell wall. For fungi and other thick-
walled microorganisms, such as mycobacteria and gram-positive
bacteria, it has been suggested that EV traverse the wall by (1)
mechanical pressure that forces EV through small pores in the
cell wall; (2) passage through protein channels in the cell wall;
and (3) remodeling/degradation of the wall by EV-associated
enzymes (detected in proteomic analyses) (Brown et al., 2015).
Different models have also been proposed to explain the
biogenesis of gram-negative bacteria-derived outer membrane
vesicles (reviewed in Pathirana and Kaparakis-Liaskos, 2016; Jain
and Pillai, 2017). For this class of bacteria, it remains to be
elucidated whether outer membrane vesicles originate from the
inner and/or outer membrane, or both (Jain and Pillai, 2017).
Since the subcellular origin of vesicles released by pathogens is
generally unknown, we will here refer to all types of pathogen-
derived vesicles as EV.
EV-ASSOCIATED MOLECULES AND
TARGETING TO RECIPIENT CELLS
There is limited knowledge on the mechanisms through which
EV can interact with cell surfaces and transfer their (intraluminal)
cargo to the recipient cell. In general, membrane-bound
(glyco)proteins and (glyco)lipids drive the initial interaction with
the recipient cell. First, the EV needs to dock at the recipient
plasma membrane where it can subsequently remain bound to
the surface, be internalized, or fuse with the cell membrane.
Receptors on the target cell plasma membrane, such as integrins,
can recognize the exterior cargo of the EV, which can lead to
activation of signaling cascades within the cell (van Niel et al.,
2018). Receptor binding may also facilitate endocytosis of the
EV, a route that targets the EV to endosomes and often further
to degradation in lysosomes. In addition to receptor-mediated
internalization, mammalian EV can also be endocytosed via non-
specific macropinocytosis, clathrin-mediated endocytosis, and
endocytosis via lipid rafts or caveolae (van Niel et al., 2018). EV
need to fuse with the limited membrane of the endosome or with
the plasma membrane in order to deliver their intraluminal cargo
such as nucleic acids, eicosanoids, and soluble proteins to the
cytosol of recipient cells. A simplified overview of EV interaction
with recipient cells can be found in Figure 1 (bottom).
Pathogen-derived EV can interact with host cells in various
ways. For example, EV from gram-negative bacteria were
shown to either fuse with the membrane of the recipient
cells or internalize via all previous mentioned routes of
endocytosis (O’Donoghue and Krachler, 2016). Additionally,
defined molecules on the surface of pathogen-derived EV may
drive their targeting to specific cells or organs in the host to create
a niche for infection and survival. Since PAMPs are abundantly
present on the surface of pathogens (Broz and Monack, 2013),
EV that bud off these membranes likely interact with PRRs
on recipient cells, as was demonstrated for bacteria-derived EV
(Pathirana and Kaparakis-Liaskos, 2016; Hashimoto et al., 2017;
Canas et al., 2018). The presence of pathogen-specific enzymes,
toxins, or PAMP-containing molecules distinguishes pathogen-
derived EV from those released by mammalian cells and may
explain differences in their uptake and function. Pathogen-
derived molecules in or on EV may therefore be exploited
in biomarker research and therapeutic applications. Examples
include the detection of parasite-derived EV-associated miRNA
in host serum as diagnostic marker for schistosome infections
and the exploration of new drugs that target the fusion of
Trypanosome EV to erythrocytes for prevention of anemia
(Zhang et al., 2018).
EFFECTS OF PATHOGEN
EV-ASSOCIATED MOLECULES ON THE
IMMUNE SYSTEM
Below, we give an overview of immunomodulatory effects
induced by components of pathogen-derived EV, subdivided
per major class of biological macromolecules (proteins, lipids,
glycans, and nucleic acids). In this way, we aim to assess
whether there are similarities in how different pathogens use
EV-associated molecules to affect host cells. This overview is
restricted to studies in which clear evidence was provided for
the association of a pathogen-specific molecule in/on EV and
the direct involvement of this molecule in the EV-induced
effects. A total overview of the selected papers, the reported EV-
associated molecules, the observed effects on the host immune
system, and the methodological approaches applied in these
studies can be found in Table 1.
Frontiers in Microbiology | www.frontiersin.org 4 September 2018 | Volume 9 | Article 2182
fmicb-09-02182 September 10, 2018 Time: 17:33 # 5
Kuipers et al. Pathogen Extracellular Vesicle-Associated Molecules
TA
B
LE
1
|P
at
ho
ge
n
E
V-
as
so
ci
at
ed
m
ol
ec
ul
es
an
d
th
ei
r
ef
fe
ct
on
ho
st
im
m
un
ity
.
M
ic
ro
b
e/
g
en
us
S
p
ec
ie
s
(s
tr
ai
n)
E
V-
as
so
ci
at
ed
m
o
le
cu
le
E
ff
ec
t
o
n
ho
st
M
et
ho
d
o
lo
g
ic
al
ap
p
ro
ac
h
a
R
ef
er
en
ce
B
ac
te
ri
a
g
ra
m
-n
eg
at
iv
e
Es
ch
er
ic
hi
a
co
li
(C
P
9)
C
N
F1
to
xi
n
A
tt
en
ua
te
s
an
tim
ic
ro
bi
al
fu
nc
tio
n
an
d
ch
em
ot
ax
is
of
m
ur
in
e
ne
ut
ro
ph
ils
D
en
si
ty
gr
ad
ie
nt
,p
ro
te
in
as
e
K
,m
ut
an
ts
tr
ai
n
D
av
is
et
al
.,
20
06
co
li
(L
B
22
66
92
)
S
hi
ga
to
xi
n
2a
A
ct
iv
at
es
ca
sp
as
e-
9
an
d
ca
sp
as
e-
3
in
hu
m
an
in
te
st
in
al
ep
ith
el
ia
lc
el
ls
re
su
lti
ng
in
ap
op
to
si
s
D
en
si
ty
gr
ad
ie
nt
,p
ro
te
in
as
e
K
,e
le
ct
ro
n
m
ic
ro
sc
op
y,
m
ut
an
ts
tr
ai
n,
bl
oc
ki
ng
co
nt
ro
li
nt
er
na
liz
at
io
n
K
un
sm
an
n
et
al
.,
20
15
H
4
fla
ge
llin
In
du
ce
s
IL
-8
se
cr
et
io
n
by
hu
m
an
in
te
st
in
al
ep
ith
el
ia
lc
el
ls
co
li
(B
L2
1)
LP
S
(li
pi
d
A
)
E
V
ta
rg
et
LP
S
to
cy
to
so
la
nd
in
du
ce
IL
1-
β
re
le
as
e
vi
a
ca
sp
as
e-
11
ac
tiv
at
io
n
in
m
ur
in
e
ce
lls
in
vi
tr
o
an
d
in
vi
vo
E
le
ct
ro
n
m
ic
ro
sc
op
ya
,m
ut
an
ts
tr
ai
na
,b
,b
lo
ck
in
g
co
nt
ro
la
,l
ip
os
om
es
b
,i
nt
er
na
liz
at
io
na
,b
a
Va
na
ja
et
al
.,
20
16
;
b
S
an
to
s
et
al
.,
20
18
co
li
(J
C
80
31
)
Le
ss
ac
et
yl
at
ed
P
N
A
G
po
ly
sa
cc
ha
rid
e
Im
m
un
iz
ed
m
ic
e
sh
ow
pr
ot
ec
tiv
e
im
m
un
e
re
sp
on
se
s
af
te
r
ch
al
le
ng
e
w
ith
un
re
la
te
d
ba
ct
er
ia
E
le
ct
ro
n
m
ic
ro
sc
op
y,
m
ut
an
ts
tr
ai
n
S
te
ve
ns
on
et
al
.,
20
18
Fr
an
ci
se
lla
t.
ho
la
rc
tic
a
(L
V
S
)
Ft
lA
lip
as
e
pr
ot
ei
n
Fa
ci
lit
at
es
ad
he
si
on
to
an
d
in
te
rn
al
iz
at
io
n
of
ba
ct
er
ia
by
m
ur
in
e
m
ac
ro
ph
ag
es
D
en
si
ty
gr
ad
ie
nt
,p
ro
te
in
as
e
K
,m
ut
an
ts
tr
ai
n
C
he
n
et
al
.,
20
17
H
el
ic
ob
ac
te
r
py
lo
ri
(2
51
)
P
ep
tid
og
ly
ca
n
(P
G
N
)
P
ro
m
ot
es
in
fla
m
m
at
io
n
in
vi
tr
o
an
d
in
vi
vo
vi
a
N
O
D
1-
de
pe
nd
en
tm
ec
ha
ni
sm
D
en
si
ty
gr
ad
ie
nt
,p
ro
te
in
as
e
K
,D
N
as
e,
m
ut
an
ts
tr
ai
n
K
ap
ar
ak
is
et
al
.,
20
10
M
or
ax
el
la
ca
ta
rr
ha
lis
(B
B
H
18
)
M
or
ax
el
la
Ig
D
-b
in
di
ng
pr
ot
ei
n
B
ce
ll
re
ce
pt
or
bi
nd
in
g
an
d
ve
si
cl
e
in
te
rn
al
iz
at
io
n
vi
a
B
ce
ll
re
ce
pt
or
E
le
ct
ro
n
m
ic
ro
sc
op
y,
D
N
as
e,
m
ut
an
ts
tr
ai
n,
bl
oc
ki
ng
co
nt
ro
l
V
id
ak
ov
ic
s
et
al
.,
20
10
D
N
A
In
cr
ea
se
s
IL
-6
an
d
Ig
M
se
cr
et
io
n
vi
a
TL
R
9
ac
tiv
at
io
n
in
hu
m
an
to
ns
illa
r
B
ce
lls
U
bi
qu
ito
us
su
rfa
ce
pr
ot
ei
ns
A
1/
A
2
D
ow
nr
eg
ul
at
io
n
of
pr
o-
in
fla
m
m
at
or
y
re
sp
on
se
in
ep
ith
el
ia
l
ce
lls
M
ut
an
ts
tr
ai
n
S
ch
aa
r
et
al
.,
20
11
N
ei
ss
er
ia
go
no
rr
ho
ea
e
(M
S
11
-A
)
P
or
B
po
rin
pr
ot
ei
n
Ta
rg
et
s
m
ito
ch
on
dr
ia
to
ac
tiv
at
e
th
e
ca
sp
as
e
pa
th
w
ay
an
d
ap
op
to
si
s
in
m
ur
in
e
m
ac
ro
ph
ag
es
D
en
si
ty
gr
ad
ie
nt
,e
le
ct
ro
n
m
ic
ro
sc
op
y,
m
ut
an
ts
tr
ai
n,
in
te
rn
al
iz
at
io
n
D
eo
et
al
.,
20
18
m
en
in
gi
tid
is
(H
44
/7
6)
LP
S
(li
pi
d
A
)
A
ct
iv
at
io
n
of
in
na
te
im
m
un
ity
in
vi
tr
o
M
ut
an
ts
tr
ai
n
Za
rir
ie
ta
l.,
20
16
P
se
ud
om
on
as
ae
ru
gi
no
sa
(P
A
14
)
C
if
to
xi
n
R
ed
uc
es
de
ub
iq
ui
tin
at
io
n
of
C
FT
R
an
d
TA
P
in
ai
rw
ay
ep
ith
el
ia
lc
el
ls
le
ad
in
g
to
re
du
ct
io
n
of
pa
th
og
en
cl
ea
ra
nc
e
an
d
an
tig
en
pr
es
en
ta
tio
n,
re
sp
ec
tiv
el
y
D
en
si
ty
gr
ad
ie
nt
,m
ut
an
ts
tr
ai
n,
in
te
rn
al
iz
at
io
n
B
om
be
rg
er
et
al
.,
20
11
,
20
14
tR
N
A
fra
gm
en
t
R
ed
uc
es
LP
S
-
an
d
E
V-
in
du
ce
d
IL
-8
re
le
as
e
by
hu
m
an
ai
rw
ay
ep
ith
el
ia
lc
el
ls
.R
ed
uc
es
ne
ut
ro
ph
il
in
fil
tr
at
io
n
in
m
ou
se
lu
ng
.
D
en
si
ty
gr
ad
ie
nt
,R
N
as
e,
m
ut
an
ts
tr
ai
n,
m
ol
ec
ul
e
co
nt
ro
l,
in
te
rn
al
iz
at
io
n
K
oe
pp
en
et
al
.,
20
16
g
ra
m
-p
o
si
ti
ve
B
ac
illu
s
an
th
ra
ci
s
(3
4F
2)
A
nt
hr
ol
ys
in
to
xi
n
po
ly
pe
pt
id
e
C
on
tr
ib
ut
e
to
cy
to
to
xi
ci
ty
in
m
ur
in
e
m
ac
ro
ph
ag
es
an
d
in
du
ce
s
Ig
M
re
sp
on
se
s
in
vi
vo
E
le
ct
ro
n
m
ic
ro
sc
op
y,
m
ut
an
ts
tr
ai
n,
bl
oc
ki
ng
co
nt
ro
l,
m
ol
ec
ul
e
co
nt
ro
l
R
iv
er
a
et
al
.,
20
10
S
tr
ep
to
co
cc
us
pn
eu
m
on
ia
e
P
sp
A
su
rfa
ce
pr
ot
ei
n
P
sp
A
sp
ec
ifi
c
Ig
G
re
sp
on
se
s
an
d
in
cr
ea
se
d
su
rv
iv
al
in
E
V
im
m
un
iz
ed
m
ic
e
D
en
si
ty
gr
ad
ie
nt
,p
ro
te
in
as
e
K
,m
ut
an
ts
tr
ai
n,
m
ol
ec
ul
e
co
nt
ro
l
M
ur
al
in
at
h
et
al
.,
20
11
Fu
ng
i
P
ar
ac
oc
ci
di
oi
de
s
br
as
ilie
ns
is
(P
b1
8,
P
b3
)
lu
tz
ii
(P
b0
1)
S
ur
fa
ce
gl
yc
an
B
in
ds
to
D
C
-S
IG
N
in
m
ic
ro
ar
ra
y;
fu
nc
tio
na
le
ffe
ct
no
t
sh
ow
n
Li
po
ph
ilic
dy
e,
bl
oc
ki
ng
co
nt
ro
l
P
er
es
da
S
ilv
a
et
al
.,
20
15
a
P
ar
as
it
es
he
lm
in
th
s
H
el
ig
m
os
om
oi
de
s
po
ly
gy
ru
s
m
iR
N
A
R
ep
re
ss
io
n
of
D
us
p1
to
in
cr
ea
se
pa
ra
si
te
su
rv
iv
al
in
ho
st
m
R
N
as
e,
lip
op
hi
lic
dy
e,
m
ol
ec
ul
e
co
nt
ro
l,
in
te
rn
al
iz
at
io
n
B
uc
k
et
al
.,
20
14
(C
on
tin
ue
d)
Frontiers in Microbiology | www.frontiersin.org 5 September 2018 | Volume 9 | Article 2182
fmicb-09-02182 September 10, 2018 Time: 17:33 # 6
Kuipers et al. Pathogen Extracellular Vesicle-Associated Molecules
TA
B
LE
1
|C
on
tin
ue
d
M
ic
ro
b
e/
g
en
us
S
p
ec
ie
s
(s
tr
ai
n)
E
V-
as
so
ci
at
ed
m
o
le
cu
le
E
ff
ec
t
o
n
ho
st
M
et
ho
d
o
lo
g
ic
al
ap
p
ro
ac
h
a
R
ef
er
en
ce
O
pi
st
ho
rc
hi
s
vi
ve
rr
in
i
Te
tr
as
pa
ni
n
(T
S
P
-1
)
pr
ot
ei
n
In
vo
lv
ed
in
E
V
up
ta
ke
an
d
su
bs
eq
ue
nt
in
du
ct
io
n
of
IL
-6
pr
od
uc
tio
n
by
hu
m
an
ch
ol
an
gi
oc
yt
es
B
lo
ck
in
g
co
nt
ro
l
C
ha
iy
ad
et
et
al
.,
20
15
p
ro
to
zo
a
Le
is
hm
an
ia
M
aj
or
,d
on
ov
an
i
G
P
63
m
et
al
lo
pr
ot
ea
se
R
ol
e
in
Le
is
hm
an
ia
E
V
pr
ot
ei
n
so
rt
in
g
w
hi
ch
in
di
re
ct
ly
da
m
pe
ns
im
m
un
e
re
sp
on
se
s.
R
ed
uc
tio
n
of
m
iR
-1
22
ex
pr
es
si
on
in
m
ou
se
liv
er
ce
lls
to
fa
vo
r
in
fe
ct
io
n.
D
en
si
ty
gr
ad
ie
nt
d
,m
ut
an
ts
tr
ai
nd
,b
lo
ck
in
g
co
nt
ro
lc
,
lip
os
om
es
c
,m
ol
ec
ul
e
co
nt
ro
lc
c
G
ho
sh
et
al
.,
20
13
;
d
H
as
sa
ni
et
al
.,
20
14
Tr
yp
an
os
om
a
cr
uz
i
tR
N
A
-
ha
lv
es
In
cr
ea
se
s
ex
pr
es
si
on
of
il-
6
an
d
cx
cl
2
in
H
eL
a
ce
lls
M
ol
ec
ul
e
co
nt
ro
l,
in
te
rn
al
iz
at
io
n
G
ar
ci
a-
S
ilv
a
et
al
.,
20
14
1
B
rie
fd
es
cr
ip
tio
n
of
m
et
ho
do
lo
gi
ca
la
pp
ro
ac
he
s:
d
en
si
ty
g
ra
d
ie
nt
,
de
ns
ity
gr
ad
ie
nt
is
ol
at
io
n
fo
r
pu
rifi
ca
tio
n
of
EV
,
of
te
n
co
m
bi
ne
d
w
ith
W
es
te
rn
B
lo
t
de
te
ct
io
n
of
th
e
EV
-a
ss
oc
ia
te
d
m
ol
ec
ul
e;
p
ro
te
in
as
e
K
,
D
N
as
e,
R
N
as
e,
pr
ot
ei
na
se
K
,
D
N
as
e,
or
R
N
as
e
tr
ea
tm
en
t
of
EV
,
of
te
n
co
m
bi
ne
d
w
ith
a
de
te
rg
en
t
or
en
zy
m
e
in
hi
bi
to
r
to
in
ve
st
ig
at
e
th
e
to
po
lo
gy
of
th
e
EV
-a
ss
oc
ia
te
d
m
ol
ec
ul
e;
el
ec
tr
o
n
m
ic
ro
sc
o
p
y
el
ec
tr
on
m
ic
ro
sc
op
y
im
m
un
og
ol
d
st
ai
ni
ng
to
sh
ow
as
so
ci
at
io
n
of
th
e
m
ol
ec
ul
e
w
ith
EV
;l
ip
o
p
hi
lic
d
ye
,s
ta
in
in
g
of
EV
m
em
br
an
e
or
EV
-d
ep
le
te
d
co
nt
ro
ls
am
pl
es
w
ith
lip
op
hi
lic
dy
e
fo
r
bi
nd
in
g/
up
ta
ke
as
sa
ys
;m
ut
an
t
st
ra
in
,E
V
fro
m
m
ut
an
t
st
ra
in
s
la
ck
in
g
th
e
(fu
nc
tio
na
l)
m
ol
ec
ul
e;
b
lo
ck
in
g
co
nt
ro
l,
us
in
g
a
co
nt
ro
lt
o
in
hi
bi
t
th
e
EV
-a
ss
oc
ia
te
d
m
ol
ec
ul
e
w
ith
ei
th
er
a
ne
ut
ra
liz
in
g
an
tib
od
y
or
co
m
po
un
d;
lip
o
so
m
es
,
m
im
ic
ki
ng
EV
by
sy
nt
he
si
s
of
lip
os
om
es
co
nt
ai
ni
ng
on
ly
th
e
m
ol
ec
ul
e
of
in
te
re
st
;
m
o
le
cu
le
co
nt
ro
l,
us
in
g
(a
sy
nt
he
tic
fo
rm
of
)
th
e
m
ol
ec
ul
e
as
a
so
lu
bl
e
pr
ot
ei
n
co
nt
ro
lt
o
co
nfi
rm
th
e
im
po
rt
an
ce
of
EV
as
so
ci
at
io
n;
in
te
rn
al
iz
at
io
n,
co
nfi
rm
ed
in
tr
ac
el
lu
la
r
de
te
ct
io
n
of
th
e
m
ol
ec
ul
e
in
re
ci
pi
en
tc
el
ls
in
cu
ba
te
d
w
ith
th
e
EV
.a
–d
,m
et
ho
do
lo
gi
ca
la
pp
ro
ac
he
s
ap
pl
ie
d
by
th
e
in
di
ca
te
d
re
fe
re
nc
es
.
Pathogen EV-Associated Proteins With
Immunomodulatory Activities
Proteins form the largest group of known pathogen EV-
associated molecules (Figure 2A). These EV proteins have been
shown to affect immune responses or the survival rates of the
host or pathogen (Figure 2B). Below, we distinguish and describe
pathogen EV-associated proteins that cause cytotoxicity, increase
pathogen survival, or induce pro-inflammatory responses.
Cytotoxic Proteins Associated to Pathogen EV
Thus far, only EV-associated proteins derived from bacteria have
shown to compromise immune defenses by inducing apoptosis
of host cells. For example, EV from the gram-negative bacterium
N. gonorrhoeae contained a porin protein, PorB, that was shuttled
to mitochondria in host macrophages (Deo et al., 2018). Here,
the voltage gated pore induced loss of mitochondria membrane
potential and cytochrome c release leading to activation of the
caspase pathway and apoptosis. As such, PorB promoted immune
evasion and survival of this sexually transmitted infection.
Importantly, it was shown that N. gonorrhoeae depends on EV
for the delivery of PorB, suggesting a role for bacteria-derived
EV and associated proteins in increased virulence. In addition,
various cytotoxic proteins were found in EV derived from a
highly virulent Escherichia coli strain (Kunsmann et al., 2015).
The authors demonstrated the association of Shiga toxin 2a
(Stx2a) and Shigella enterotoxin 1 with the EV. Stx2a was shown
to cause cytotoxicity after EV uptake by various human intestinal
epithelial cell lines via activation of caspase-9 and caspase-3. This
effect could not be reduced by preincubating the EV with a Stx2a-
neutralizing antibody, confirming the intravesicular localization
of Stx2a (Kunsmann et al., 2015).
Extracellular vesicle released by the gram-positive bacteria
Bacillus anthracis were also shown to contain cytotoxic molecules
(Rivera et al., 2010). The anthrax toxins released by this bacterium
have lethal consequences for its host during infection. Both EV-
associated anthrolysin (a cholesterol-dependent pore-forming
protein) and an anthrax toxin polypeptide induced toxicity in
macrophages. Additional effects of these EV-associated toxins
were shown in immunized mice. Immunization with isolated EV
from B. anthracis increased the survival of mice after bacterial re-
challenge and led to an increase in IgM titers against B. anthracis
toxins in mouse sera. This differed from immunization with
purified, non-EV associated toxins, which mainly induced IgG
production (Rivera et al., 2010).
EV-Associated Proteins Promoting Survival of
Pathogens
Bacteria-derived toxins transported by EV can also modulate
immune cell functions to promote pathogen survival. For
example, cytotoxic necrotizing factor type 1 (CNF1) in EV from
an uropathogenic E. coli was shown to reduce antimicrobial
activity and chemotactic responses in neutrophils (Davis et al.,
2006). Another example has been provided for the Cif
toxin derived from the gram-negative bacterium Pseudomonas
aeruginosa (Bomberger et al., 2011, 2014). EV-associated Cif
increased the bacterial pathogenesis of P. aeruginosa by reducing
the abundance of the cystic fibrosis transmembrane conductance
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FIGURE 2 | Immunomodulatory molecules in pathogen-derived EV. (A) Schematic summary of pathogen-derived EV-associated molecules with immunomodulatory
effects released by bacteria (green), fungi (orange), and parasites (purple), subdivided in proteins, lipids, glycans, and nucleic acids. The suggested topology of the
molecules, i.e., inside the EV or in its lipid membrane facing the exterior, is also shown. (B) Defined EV-associated molecules released by pathogens arranged based
on immunomodulatory effects, i.e., pathogen survival, inflammatory response, and immune cell apoptosis.
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regulator (CFTR) in human airway epithelial cells. CFTR
facilitates chloride secretion by epithelial cells needed for
mucociliary clearance of the pathogen in the lungs (Bomberger
et al., 2011). In a follow-up paper, it was suggested that Cif may
also increase the severity and duration of infections in the airways
by reducing the ‘transporter associated with antigen processing 1’
(TAP1). This leads to reduced antigen transport to MHC class
I molecules and inhibition of antigen presentation, including
antigens from other pathogens such as viruses (Bomberger et al.,
2014). These studies suggest that Cif can contribute to pathogen
survival in various ways. Another human respiratory pathogen,
Moraxella catarrhalis, was shown to release EV that reduced
TLR2-induced IL-8 production by human alveolar epithelial
cells, via the activity of EV-associated Ubiquitous surface protein
(Usp)A1. UspA1 can bind to carcinoembryonic antigen-related
cell adhesion molecule-1 (CEACAM-1) on epithelial cells and
subsequently reduce TLR2-activated IL-8 production (Schaar
et al., 2011). As IL-8 is a key player to attract other cells, mainly
neutrophils, to the site of infection, UspA1-dependent reduction
of IL-8 could increase bacterial survival in the lungs.
Extracellular vesicle from zoonotic Francisella tularensis,
the gram-negative bacterium that can cause fetal pneumonic
tularemia in humans, contain a protein with lipolytic activity
named FtlA. Since this bacterium primarily replicates inside
alveolar macrophages and epithelial cells, the success of invasion
into host cells determines its virulence. FtlA mutant bacteria
showed significantly reduced lipolytic activity and virulence and
reduced inflammatory cell infiltrations in a lung infection model
(Chen et al., 2017). Interestingly, it was shown that FtlA is
absent from the surface of the bacterium but present on the
surface of EV from F. tularensis. By adding EV from the wild
type strain to ftlA mutant bacteria in vitro, bacterial infiltration
increased significantly, suggesting a role for the EV-associated
lipase protein in bacterial adhesion and cell invasion (Chen et al.,
2017).
In addition to gram-negative bacteria, parasites also release
EV that promote survival in the host. This was shown for
EV containing Glycoprotein (GP)63 released by the protozoan
parasite L. major (Hassani et al., 2014). GP63 is a zinc-
dependent metalloprotease that is expressed on the surface of the
infectious Leishmania life stage. Parasite-derived GP63 is known
to modulate signaling pathways (such as tyrosine phosphatases)
within macrophages such that it inhibits inflammatory responses
leading to increased parasite survival. Although this is an
intracellular parasite, the authors used isolated EV from in vitro
extracellular parasite cultures. In vivo administration of EV
from GP63−/− L. major parasites resulted in stronger pro-
inflammatory effects, such as increased neutrophil and eosinophil
recruitment, compared to wild type L. major. This suggests that
EV-associated GP63 could dampen immune responses and may
support the establishment of Leishmania infection in the host.
However, these effects could also be due to other EV-associated
proteins, since it was shown that GP63 additionally affects the
proteomic content of EV (Hassani et al., 2014). Furthermore,
EV-associated GP63 was shown to affect liver cell function. GP63-
containing EV released by L. donovani reduced the activity of
miRNA miR-122 in a human liver cell line, likely by affecting
DICER1-mediated cleavage of this miRNA (Ghosh et al., 2013).
These results were confirmed in vivo by administering liposomes
containing purified GP63 or Leishmania-derived EV to mice. The
GP63-induced reduction in DICER1 and miR-122 expression in
hepatocytes resulted in metabolic changes in these cells and lower
serum cholesterol levels. This may favor parasite infection, as a
high serum cholesterol is associated with reduced parasite burden
in the liver (Ghosh et al., 2013).
Pro-inflammatory Responses Induced by
EV-Associated Proteins
In addition to their cytotoxic and survival-promoting effects,
pathogen-derived EV have also been implicated in raising host
immune responses against the pathogens. EV from the liver
fluke (flatworm) Opisthorchis viverrini, for example, were shown
to induce IL-6 production by human cholangiocytes, an effect
that could be blocked by antibodies against the EV-associated
tetraspanin TSP-1 (Chaiyadet et al., 2015). This suggested a role
for TSP-1 carrying EV in the chronic inflammatory environment
observed in host tissues during infection with O. viverrini.
Also EV-associated proteins from bacteria can induce pro-
inflammatory responses in the host. This has been shown
for virulent E. coli-derived EV-associated H4 flagellin, which
triggered TLR5 signaling and subsequent IL-8 release by EV-
targeted intestinal cells (Kunsmann et al., 2015). An additional
way in which pro-inflammatory responses are induced by EV
was shown for M. catarrhalis. Moraxella IgD-binding (MID)
protein on the EV of this gram-negative bacterium was essential
for EV uptake by human tonsillar B lymphocytes via the B cell
receptor and induced IL-6 production by these cells (Vidakovics
et al., 2010). Interestingly, IgM production was increased after
B cell uptake of EV, but these antibodies were not specific for
Moraxella bacteria. The authors therefore suggested that the non-
specific IgM production induced by MID-associated EV is rather
a survival strategy to divert the B cell antibody production away
from the bacterial infection (Vidakovics et al., 2010). These results
suggest that one EV-associated protein may induce multiple
effects that could benefit both the host and the pathogen.
Overall, these findings indicate that a wide variety of
pathogen-derived EV-associated proteins can modulate host
immune responses. The pro-inflammatory properties of
pathogen-derived EV may be used for EV-based vaccination
strategies. This has been investigated for PspA, a surface protein
expressed by all strains of the gram-positive Streptococcus
pneumoniae. PspA was introduced into a gram-negative
Salmonella enterica strain (Muralinath et al., 2011), after
which EV released by these bacteria were used for intranasal
immunization of mice. These EV induced a PspA-specific IgG
responses and increased mouse survival after S. pneumoniae
challenge. This was not observed when administrating EV from
a similar Salmonella strain without PspA or when PspA was
administered as purified antigen (Muralinath et al., 2011).
EV-Associated Lipids
Bacterial LPS is the most intensely investigated pathogen-
derived (glyco)lipid associated with EV. LPS is known to bind
to TLR4, but can also be recognized in the cytosol by the
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murine receptor protease caspase-11, and in humans by caspase-
4 and caspase-5. EV from gram-negative bacteria were shown
to deliver LPS to the cytosol, thereby inducing an inflammatory
form of programmed cell death (pyroptosis) and increased
IL-1β expression in a caspase-11-dependent manner (Vanaja
et al., 2016). These effects were reduced when LPS on EV was
neutralized, when EV from an E. coli mutant lacking a functional
lipid A (an essential component of LPS) were used, or when
cells were incubated with EV from gram-positive bacteria lacking
LPS. The pro-inflammatory effects were also reduced when using
bacteria from a E. coli strain which released less EV due to
mutations in EV biogenesis. These data suggest a role for EV
in delivering LPS into the cytosol and subsequent activation
of innate immune responses during an infection with gram-
negative bacteria (Vanaja et al., 2016). A more recent study
confirmed these findings by mimicking the EV structure of gram-
negative bacteria by incorporation of LPS in liposomes (Santos
et al., 2018). When stimulating murine macrophages with these
liposomes, cell death and IL-1β release were induced in a caspase-
11-dependent fashion. In addition, a role for guanylate-binding
proteins (GBPs) in this process was observed. GBPs can destroy
the membrane of pathogens in the cytosol. It was suggested
that EV-associated LPS recruits GBPs, which then engage in
a membrane-disrupting activity leading to either LPS release
from the EV or providing direct access of caspase-11 to the
lipid A moiety of LPS, both resulting in caspase-11 activation
(Santos et al., 2018). Lipid A was indeed shown to be essential
for GBP-dependent cell death. Additionally, injection of LPS-
containing E. coli-derived EV into wild type mice caused lethality,
while GBP−/− mice showed increased survival and caspase-11
deficient mice showed complete survival. This suggests a role for
EV-associated LPS in EV-induced endotoxic shock.
Extracellular vesicle-associated lipids are also gaining
attention in the development of EV-based vaccines (Lener
et al., 2015). EV derived from the gram-negative bacterium
N. meningitidis are already used in a vaccine against
meningococcal disease in children (Acevedo et al., 2014).
Research has been performed on how different types and
modifications of LPS in EV from gram-negative bacteria
contribute to immunogenicity or (endo)toxicity (Vanaja et al.,
2016). Lipid A modifications in N. meningitidis mutants, for
example, were shown to reduce EV-induced innate immune
responses in vitro, which could indicate these EV are less
endotoxic and thus probably safer to use in vaccines (Zariri et al.,
2016).
Thus far, only the above described studies gave strong proof
of the presence of biologically active (glyco)lipids in pathogen-
derived EV (see Figure 2A). Considering the increasing interest
in EV and continuous improvement of EV isolation and
characterization technologies, it is suspected that additional
biological effects of pathogen-derived EV-associated lipids may
be elucidated in the near future. For example, mass spectrometry
indicated that EV from the parasitic worm Heligmosomoides
polygyrus differed in lipid composition from murine cell-
derived EV and were enriched in ether glycerophospholipids
called plasmalogens. The authors created artificial vesicles and
observed that increasing the plasmalogen content of the vesicles
increased the efficiency with which they fused with cells (Simbari
et al., 2016). However, it remains to be elucidated whether
plasmalogens influence the immunomodulatory property of
these EV.
Glycans Associated to EV
Several lines of evidence indicate that glycans are present on
EV from bacteria, parasites, and fungi. Pathogen glycans can
bind to and signal via different host cell receptors, which may
lead to modification of host cell function. For example, using
mammalian lectin microarrays, it was shown that surface glycans
on EV of the fungi Paracoccidioides brasiliensis and P. lutzii were
recognized by human DC-SIGN (Peres da Silva et al., 2015a). In
addition, analysis of the proteomes of parasite-derived EV has
indicated the presence of many (putative) glycoproteins (Twu
et al., 2013; Nowacki et al., 2015; Samoil et al., 2018). Whether or
how these components truly interact with host cells and modify
their function it is not yet known.
While no data are available on potential immunomodulatory
effects of glycans associated to fungi- or parasite-derived EV,
several studies addressed the function of glycans on bacteria-
derived EV. Mice immunized with EV from a genetically
engineered E. coli with decreased acetylation of poly-N-acetyl-
D-glucosamine (PNAG) showed higher protective immune
responses after bacterial challenge compared to their highly
acetylated counterparts (Stevenson et al., 2018). PNAG is a
surface polysaccharide present in many different pathogen
species, suggesting that these engineered EV as immunization
strategy may be broadly effective. Indeed, immunized mice
were protected against lethal doses of Staphylococcus aureus and
F. tularensis. In another study, EV from Helicobacter pylori were
shown to induce NF-κB activity and subsequent IL-8 production
in human epithelial cell lines in an NOD1-dependent fashion
(Kaparakis et al., 2010). Cytosolic NOD1 is known to specifically
recognize peptidoglycan, a component of the bacterial cell wall.
The authors indeed showed that EV-associated peptidoglycan
from gram-negative bacteria could activate NOD1. Interestingly,
feeding of mice with EV from H. pylori increased gastric
gene expression of the chemokine Cxcl2, which was shown to
be dependent on NOD1 and independent of TLR activation
(Kaparakis et al., 2010). However, it remains to be determined
whether association of peptidoglycan with EV is required to
mediate these effects.
Thus far, only a handful of studies have investigated the
glycome of EV, none of which addressed pathogen EV (reviewed
by Gerlach and Griffin, 2016; Williams et al., 2018), partly due to
the technical limitations dictated by the scale and purity of EV
preparations. The importance of analyzing the glycomic profiles
of EV has been demonstrated for mammalian EV. In different
pathological conditions, such as cancer or metabolic diseases,
differences were observed in the EV glycomic profile (Escrevente
et al., 2011; Staubach et al., 2012; Gerlach et al., 2013), suggesting
the physiological importance of EV glycosylation. Studying
glycomic profiles of pathogen-derived EV could improve our
understanding of EV biogenesis and interaction with recipient
cells, and elucidate whether glycosylation of proteins and lipids
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plays a role in (immune) modulation by these EV (Williams et al.,
2018).
EV-Associated Nucleic Acids
The nucleic acid content of pathogen-derived EV consists of
different RNA classes and DNA. Depending on the type of
nucleic acid and its localization in the EV these molecules can
either regulate host mRNA or trigger RNA or DNA sensing
receptors. The latter was observed for EV of the gram-negative
bacterium M. catarrhalis (Vidakovics et al., 2010). These vesicles
were shown to induce the proliferation of human tonsillar
B cells and activate TLR9 via its EV-associated DNA that
contained CpG-motifs. Furthermore, it was observed that the
increase in B cell proliferation was significantly reduced when
EV were treated with DNase, suggesting that the DNA is on the
outside surface of M. catarrhalis-released EV (Vidakovics et al.,
2010).
There is an increasing number of studies that report on
the composition of the small RNA repertoires in vesicles from
bacteria (Blenkiron et al., 2016; Koeppen et al., 2016), fungi
(Peres da Silva et al., 2015b), and parasites (Bernal et al., 2014;
Buck et al., 2014; Garcia-Silva et al., 2014; Hansen et al., 2015;
Nowacki et al., 2015; Zamanian et al., 2015; Zhu et al., 2016).
However, so far, only few studies provided evidence that EV-
associated RNA is responsible for the modulation of host cells.
For example, uptake of EV from the gastrointestinal parasitic
worm H. polygyrus by mouse epithelial cells led to decreased
expression of the Dusp1 gene while uptake of EV from mouse
intestinal cells had no effect (Buck et al., 2014). This effect is
likely caused by the EV-associated miRNAs, since transfection of
host cells with synthetic analogs of these parasite miRNAs also
showed reduction of Dusp1 expression. DUSP1 is a regulator of
mitogen-activated protein kinase (MAPK) signaling and favors
a reduction in IL-6 and an increase in macrophage arginase
expression. As IL-6 enhances host susceptibility to H. polygyrus
and arginase is a mediator of killing this parasite in mice,
repression of DUSP1 may be a parasite-driven mechanism to
enhance its survival in the host. This is a very interesting
example of cross-organism communication in which a parasite
EV-associated miRNA functions due to complementarity to the
host target gene.
Immunomodulatory effects induced by other EV-associated
small non-coding RNAs have been described for both parasites
and bacteria. The parasite T. cruzi releases EV containing transfer
RNA-derived small RNAs (tsRNA), that could be visualized
inside HeLa cells after uptake of these EV (Garcia-Silva et al.,
2014). This led to several alterations in gene expression levels,
including increased mRNA levels for pro-inflammatory il-6 and
cxcl2. Part of this effect, such as increased cxcl2 expression,
was also observed when HeLa cells were transfected with a
synthetic form of the most abundant EV-associated tsRNAs
(Garcia-Silva et al., 2014). However, the mechanism by which
tsRNA derived from parasite influences host mRNA transcription
remains to be elucidated. EV-associated tRNA-derived fragments
(from different isoacceptor tRNAs) were also detected in EV
from the opportunistic bacterium P. aeruginosa (Koeppen et al.,
2016). One specific tsRNA (sRNA52320) present in isolated EV
could be detected inside EV-treated primary human bronchial
epithelial cells. Both EV-mediated transfer of sRNA52320 and
direct transfection of cells with synthetic sRNA52320 led
to reduction of LPS-induced IL-8 production. This provided
indirect evidence that EV-enclosed tRNAs mediated these effects.
Also in vivo, P. aeruginosa-derived EV significantly reduced
the mouse homolog of IL-8 in bronchoalveolar lavage fluid
and lowered lung neutrophil infiltration, which was sRNA52320
dependent (Koeppen et al., 2016). However, whether the EV-
associated tsRNA contributes to persistence of P. aeruginosa
infections is yet to be determined.
CONCLUSION AND OUTLOOK
The observed effects of EV released by pathogens underline that
intercellular communication via EV is a conserved mechanism
that most likely benefits pathogen survival in co-evolution
with its host. Immunomodulatory components of pathogen-
derived EV are represented in all molecular subclasses—
proteins, lipids, glycans, and nucleic acids (Figure 2A)—and
can modify host cell function or induce host cell apoptosis.
Although the field of research on pathogen-derived EV is
still in its infancy, many advanced studies have already been
performed on EV released by bacteria. The generation of mutant
bacterial strains has provided great opportunities to study the
function of specific EV-derived molecules. From these studies,
we learned that many, if not all, gram-negative bacteria release
LPS-containing EV that are well-capable of inducing pro-
inflammatory reactions. Despite gaps in our understanding of the
broad group of pathogen-derived EV, the currently available data
indicate that pathogen EV-associated molecules can promote
survival and spreading of pathogens, but can also facilitate the
induction of host-immune responses (Figure 2B). The exact
role of pathogen-derived EV in host–pathogen interaction likely
depends on pathogen life stage, environmental, and/or tissue
specific conditions.
The current overview does not show us yet whether EV from
different pathogens contain conserved classes of molecules or
act via similar principles. This is probably due to the limited
number of publications on EV-associated immunomodulatory
molecules from pathogens that is available at this early stage. In
addition, inter-study comparability of data on both mammalian
and pathogen EV is currently hampered by the use of a
wide range of different techniques to isolate and characterize
EV. Different EV isolation methods, for example, yield EV
of different purity and can bias toward isolating certain EV
subtypes (Mateescu et al., 2017). This urges the need to adhere
to guidelines stated in the “minimal information for studies
of EV (MISEV)” (Lotvall et al., 2014), of which an update
is currently under development. Increasing the reproducibility
of EV research also requires that all experimental details
relating to EV isolation and characterization are reported in
scientific publications. This is facilitated by EV-TRACK, which
is a crowdsourcing knowledgebase to centralize experimental
parameters of EV publications (Van Deun et al., 2017).
Optimization and standardization of experimental methods will
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help to unravel effects of specific EV-associated molecules from
pathogens and is particularly important for the design of, e.g., EV-
based vaccines. Additionally, a more standardized approach will
allow the comparison of similar molecules or immune responses
induced by different pathogen-derived EV.
A promising method to allow pathogen-overarching
comparisons of pathogen-derived EV-associated molecules is the
use of bioinformatics (Bryant et al., 2017). The increasing number
of publications on molecular characterization of pathogen-
derived EV will generate large databases, such as EVpedia
(Kim et al., 2013), with a wide range of omics data ready to
be investigated in silico. Computer-based models can search
all available pathogen specific EV-associated molecules for
family members with immunomodulatory potential that are
conserved between different pathogens, and directly point toward
interesting molecules for further functional studies. Increasing
the knowledge on pathogen-derived EV-associated molecules
and their effects on the host immune system will certainly shed
further light on the importance of EV molecules in infection
biology.
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